2011 - Distinguished Fellowship Award, American College of Cardiology (ACC)
The scientist’s investigation covers issues in Internal medicine, Cardiology, Brugada syndrome, Repolarization and QT interval. His Internal medicine research incorporates elements of Anesthesia and Endocrinology. His study in Long QT syndrome, Ventricular tachycardia, Ventricular fibrillation, Torsades de pointes and Sudden cardiac death is done as part of Cardiology.
His Brugada syndrome study combines topics in areas such as Mutation, Missense mutation, Ajmaline, Sudden death and Flecainide. His Repolarization study integrates concerns from other disciplines, such as T wave alternans, Depolarization and Reentry. His QT interval study deals with Heart block intersecting with Bundle branch block.
Charles Antzelevitch mainly investigates Internal medicine, Cardiology, Brugada syndrome, Repolarization and Sudden cardiac death. His research ties Endocrinology and Internal medicine together. The Endocrinology study combines topics in areas such as Mutation and Missense mutation.
His studies link Anesthesia with Cardiology. His Brugada syndrome study which covers Sodium channel that intersects with Pharmacology and Ranolazine. His work deals with themes such as T wave, Myocyte and Cardiac transient outward potassium current, which intersect with Repolarization.
His scientific interests lie mostly in Internal medicine, Cardiology, Brugada syndrome, Sudden cardiac death and Ventricular fibrillation. His Ventricular tachycardia, Cardiac arrhythmia, Fibrillation and Repolarization study, which is part of a larger body of work in Internal medicine, is frequently linked to In patient, bridging the gap between disciplines. He has included themes like Endocardium and Ajmaline in his Repolarization study.
His study connects Tpeak tend and Cardiology. His research in Brugada syndrome intersects with topics in QRS complex, Long QT syndrome, Risk stratification, Cardiac transient outward potassium current and ST segment. His Sudden cardiac death research is multidisciplinary, incorporating perspectives in Bioinformatics, Implantable cardioverter-defibrillator, Short QT syndrome, Penetrance and Sudden cardiac arrest.
His primary areas of study are Internal medicine, Cardiology, Brugada syndrome, Sudden cardiac death and Long QT syndrome. His work on Internal medicine is being expanded to include thematically relevant topics such as Anesthesia. Many of his studies on Cardiology involve topics that are commonly interrelated, such as Sodium channel blocker.
Charles Antzelevitch has researched Brugada syndrome in several fields, including Ajmaline, Cardiac conduction, Sudden death, Cardiac arrhythmia and Mutation. His Sudden cardiac death research includes themes of Implantable cardioverter-defibrillator and Intensive care medicine. His Long QT syndrome research incorporates elements of Genetics, Channelopathy and Cardiac action potential.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Contemporary Definitions and Classification of the Cardiomyopathies An American Heart Association Scientific Statement From the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention
Barry J. Maron;Jeffrey A. Towbin;Gaetano Thiene;Charles Antzelevitch.
Circulation (2006)
Brugada Syndrome: Report of the Second Consensus Conference Endorsed by the Heart Rhythm Society and the European Heart Rhythm Association
Charles Antzelevitch;Pedro Brugada;Martin Borggrefe;Josep Brugada.
Circulation (2005)
Genetic basis and molecular mechanism for idiopathic ventricular fibrillation
Qiuyun Chen;Glenn E. Kirsch;Danmei Zhang;Ramon Brugada.
Nature (1998)
Proposed diagnostic criteria for the Brugada syndrome: consensus report.
Arthur A.M. Wilde;Charles Antzelevitch;Martin Borggrefe;Josep Brugada.
Circulation (2002)
Cellular Basis for the Brugada Syndrome and Other Mechanisms of Arrhythmogenesis Associated With ST-Segment Elevation
Gan-Xin Yan;Charles Antzelevitch.
Circulation (1999)
Cellular Basis for the Normal T Wave and the Electrocardiographic Manifestations of the Long-QT Syndrome
Gan-Xin Yan;Charles Antzelevitch.
Circulation (1998)
Cellular Basis for the Electrocardiographic J Wave
Gan-Xin Yan;Charles Antzelevitch.
Circulation (1996)
Heterogeneity within the ventricular wall. Electrophysiology and pharmacology of epicardial, endocardial, and M cells.
C. Antzelevitch;S. Sicouri;S. H. Litovsky;A. Lukas.
Circulation Research (1991)
Sudden death associated with short-QT syndrome linked to mutations in HERG.
Ramon Brugada;Kui Hong;Robert Dumaine;Jonathan Cordeiro.
Circulation (2003)
Sodium Channel Blockers Identify Risk for Sudden Death in Patients With ST-Segment Elevation and Right Bundle Branch Block but Structurally Normal Hearts
Ramon Brugada;Josep Brugada;Charles Antzelevitch;Glenn E. Kirsch.
Circulation (2000)
Journal of the American College of Cardiology
(Impact Factor: 27.203)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Florida
University of Barcelona
Nippon Medical School
Vrije Universiteit Brussel
University of Amsterdam
University of Girona
Istituto Auxologico Italiano
University of Padua
Mayo Clinic
Spanish National Centre for Cardiovascular Research
University of Nottingham
University of Basel
Dartmouth College
Leiden University
University of Michigan–Ann Arbor
Örebro University
University of Tübingen
University of Washington
Boston Children's Hospital
University of Minnesota
Macquarie University
Yale University
KU Leuven
Kaiser Permanente
University of Birmingham
Northwestern University